High frequency of secondary, but not primary ocular manifestations of inflammatory bowel disease in patients treated at a tertiary care center

被引:9
|
作者
Walldorf, Jens [1 ]
Twarz, Maria [1 ]
Schober, Celestina [2 ]
Michl, Patrick [1 ]
Hammer, Thomas [2 ]
机构
[1] Martin Luther Univ Halle Wittenberg, Dept Internal Med 1, Halle, Germany
[2] Martin Luther Univ Halle Wittenberg, Dept Ophthalmol, Halle, Germany
关键词
extraintestinal manifestations; eye; inflammatory bowel disease; ocular manifestation; ophthalmology; EXTRAINTESTINAL MANIFESTATIONS; CROHNS-DISEASE; DIAGNOSIS; PREVALENCE;
D O I
10.1097/MEG.0000000000001248
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective Ocular manifestations of inflammatory bowel disease (IBD) are relevant complications of IBD. Only a few prospective studies are available on the characteristics of these manifestations. The aim of this study was to characterize the frequency of eye disease in patients with IBD, including primary and secondary ocular manifestations of IBD, and to identify patients who may need specialized ophthalmologic care. Patients and methods In a prospective observational study, patients with IBD were examined for ocular symptoms in comparison with control participants without IBD. All patients with IBD underwent a thorough ophthalmologic examination (including slit-lamp, tonometry, tear breakup time, Schirmer's test, and coherence tomography). The results were analyzed with respect to sociodemographic and disease-related characteristics. Results A total of 61 patients (33 women, 39 Crohn's disease, 22 ulcerative colitis, age 43.3 +/- 12.9 years, disease duration 12.4 +/- 9.3 years) were included. Ophthalmologic symptoms were reported by 53 patients (86.9%, most frequently deterioration of vision 42.6%, foreign body sensation 36.1%) compared with 60.6% in healthy controls (P = 0.001). A clinically relevant, previously undetected ophthalmologic diagnosis was identified in 56 patients (91.8% - dry eye syndrome 75.4%, cataract 67.2%, blepharitis 45.9%, fundus hypertonicus 14.8%, other 16.4%). Conclusion Although primary ocular manifestations of IBD are rare in intensively treated patients, the high frequency of unrecognized secondary manifestations should give reason to refer especially patients with longstanding or complicated IBD to an eye specialist - irrespective of ocular symptoms. Copyright (C) 2018 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:1502 / 1506
页数:5
相关论文
共 50 条
  • [21] Articular Manifestations in Patients with Inflammatory Bowel Disease Treated with Vedolizumab
    Dupre, Anastasia
    Collins, Michael
    Carbonnel, Franck
    Mariette, Xavier
    Seror, Raphaele
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [22] Articular manifestations in patients with inflammatory bowel disease treated with vedolizumab
    Dupre, Anastasia
    Collins, Michael
    Nocturne, Gaetane
    Carbonnel, Franck
    Mariette, Xavier
    Seror, Raphaele
    RHEUMATOLOGY, 2020, 59 (11) : 3275 - 3283
  • [23] Predictors of Readmissions in Hospitalized Patients With Inflammatory Bowel Disease Treated at a Tertiary Care Hospital
    Christian, Kaci E.
    Jambaulikar, Guruprasad D.
    Hagan, Matilda
    Campbell, Earl V.
    Brown, Sara
    Gadani, Akash
    Syed, Ali
    Briscoe, Jessica
    Cross, Raymond
    GASTROENTEROLOGY, 2015, 148 (04) : S261 - S262
  • [24] ARTICULAR MANIFESTATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB
    Dupre, Anastasia
    Collins, Michael
    Carbonnel, Franck
    Mariette, Xavier
    Nocturne, Gaetane
    Seror, Raphaele
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1240 - 1241
  • [25] MUSCULOSKELETAL MANIFESTATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB
    Rodriguez-Merlos, P.
    Ruiz-Ramirez, M. A.
    Plasencia, C.
    Navarro-Compan, V.
    Suarez-Ferrer, C.
    Martin-Arranz, E.
    Martin Arranz, M. D.
    Peiteado, D.
    Bonilla, G.
    Sanchez Azofra, M.
    Poza Cordon, J.
    Franco Gomez, K. N.
    Balsa, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 731 - 732
  • [26] Vaccinations in Patients with Inflammatory Bowel Disease and Rheumatoid Arthritis on Immunosuppressants: Primary Care Physician Awareness and Current Practices at a Tertiary Care Center
    Khov, Nancy
    Elwir, Saleh
    Jain, Vishal
    Olsen, Nancy
    Williams, Emmanuelle
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S646 - S646
  • [27] A descriptive study of inflammatory bowel disease at an Egyptian tertiary care center
    El-Atrebi, K. A.
    Taher, E.
    El Aguizy, F. H.
    Ali, R. M.
    Hegazy, A.
    El-Sayed, M. M.
    Eysa, B.
    El-Atreby, A. A.
    Mohammed, A. A.
    El-Bassyouni, H. T.
    REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2023, 88 (01): : 12 - 18
  • [28] Trends of inflammatory bowel disease at a tertiary care center in northern India
    Sood, Ajit
    Kaur, Kirandeep
    Singh, Arshdeep
    Midha, Vandana
    Mahajan, Ramit
    Bansal, Namita
    Mehta, Varun
    Singh, Dharmatma
    INTESTINAL RESEARCH, 2021, 19 (03) : 282 - +
  • [29] Seasonal Variation in HRQOL and Disease Activity in Patients with Inflammatory Bowel Disease: A Tertiary Care Center Experience
    Beaulieu, Dawn B.
    Ananthakrishnan, Ashwin N.
    Zadvomova, Yelena
    Stein, Daniel J.
    Mepani, Rachel
    Antonik, Stephen J.
    Skaros, Susan
    Johnson, Kathryn
    Naik, Amar S.
    Perera, Lilani P.
    Binion, David G.
    GASTROENTEROLOGY, 2009, 136 (05) : A362 - A362
  • [30] Hepatobiliary and pancreatic manifestations in inflammatory bowel disease: Data from tertiary referral center
    Satai, Mayur
    Vaidya, Arun
    Kale, Aditya
    Gopan, Amrit
    Abu Ansari
    Shukla, Akash
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 85 - 85